Abstract
Cytogenetic analyses performed on human solid tumors have shown, for some of them characteristic patterns of chromosomes anomalies. To understand the meaning of recurrent chromosomal imbalances, it was postulated that they could be related to specific metabolic modifications. This hypothesis was first tested on colorectal carcinomas1, 2, 3 and verified on gliomas, by comparing tumor samples to corresponding normal tissue4, 5. In an attempt to precise the role of chromosomal aberrations, it appeared of interest to develop a metabolic study of three tumors, presenting either similar or distinct cytogenetic patterns, in order to compare their metabolic patterns.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
C. Luccioni, M. Muleris, L. Sabatier, and B. Dutrillaux, Chromosomal and enzymatic patterns provide evidence for two types of human colon cancers with abnormal nucleotides metabolism, Mutation Res. 200: 55–62 (1988).
V. Bardot, C. Luccioni, D. Lefrançois, M. Muleris, and B. Dutrillaux, Activity of thymidylate synthase, thymidine kinase and galactokinase in primary and xenografted human colorectal cancers in relation to their chromosomal patterns, Int. J. Cancer 47: 670–674 (1991).
A. Bravard, C. Luccioni, M. Muleris, D. Lefrançois, and B. Dutrillaux, Relationships between UMPK and PGD activities and deletions of chromosome lp in colorectal cancers, Cancer Genet. Cytogenet. 56: 45–56 (1991).
V. Bardot, A.M. Dutrillaux, C. Luccioni et al, Anomalies chromosomiques et métabolisme de l’adénine dans les tumeurs gliales humaines, Reu Neurol (Paris) 148: 408–416 (1992).
V. Bardot, A.M. Dutrillaux, J.Y. Delattre, F. Vega, M. Poisson, B. Dutrillaux, and C. Luccioni, Purine and pyrimidine metabolism in human gliomas, in relation to chromosomal aberrations, Br. J. Cancer (In Press).
S.H. Bigner, J. Mark, and D.D. Bigner, Cytogenetic of human brain tumors, Cancer Genet. Cytogenet. 47: 141–154(1990).
S.H. Bigner, J. Mark, P.C. Burger, M.S. Mahaley D.E. Bullard, L.H. Muhlbaier, and D.D. Bigner, Specific chromosomal abnormalities in malignant gliomas, Cancer Res. 48: 405–411 (1988).
G. Thiel, T. Losanowa, D. Kintzel et al, Karyotypes in 90 human gliomas, Cancer Genet. Cytogenet. 58: 109–120(1992).
J. Limon, P. Dal Cin, S.N.J. Sait, C. Karakousis, and A.A. Sandberg, Chromosome changes in metastatic human melanoma, Cancer Genet. Cytogenet. 30: 201–211 (1988).
P.C. Nowell, Cytogenetic of tumor progression, Cancer 65: 2172–2177 (1990).
G. Balaban, M. Herlyn, D. Guerry, R. Bartelo, H. Koprowski, W.H. Clark, and P.C. Nowell, Cytogenetics of human malignant melanoma and premalignant lesions, Cancer Genet. Cytogenet. 11: 429–439(1984).
B. Dutrillaux, and M. Muleris, Induction of increased salvage pathways of nucleotide synthesis by dosage effect due to chromosome imbalances may be fundamental in carcinogenesis: the example of colorectal carcinoma, Ann. Genet. 29: 11–15 (1986).
F. Plénat, A. Duprez, Chimérisme tissulaire homme-souris nude: caractérisation des populations cellulaires par hybridation in situ, C. R. Acad. Sci. Paris 310: 53–59 (1990).
D. Lefrançois, S. Olschwang, O. Delattre, M. Muleris, A.M. Dutrillaux, G. Thomas, and B. Dutrillaux, Preservation of chromosomal and DNA characteristics of human colorectal carcinomas after passages in nude mice, Int. J. Cancer 44: 871–878 (1989).
G.W. Crabtree, D.L. Dexter, J.D. Stoeckler, T.M. Savarese, L.Y. Ghoda, et al, Activities of purine-metabolizing enzymes in human colon carcinoma cell lines and xenograft tumors, Biochemical Pharmacology 30: 793–798 (1981).
Y. Natsumeda, N. Prajda, J.P Donohue, J.L. Glover, and G. Weber, Enzymic capacities of purine de novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues, Cancer Res. 44: 2475–2479 (1984).
Y. Natsumeda, M.S. Lui, J. Emrani, M.A. Faderan, M.A. Reardon, J.N. Eble, J.L. Glover, and G. Weber, Purine enzymology of human colon carcinomas, Cancer Res. 45: 2556–2559 (1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bardot, V. et al. (1995). Purine and Pyrimidine Metabolisms in Human Gliomas, Melanomas and Colon Carcinomas Xenografts, Relation to their Cytogenetic Profile. In: Sahota, A., Taylor, M.W. (eds) Purine and Pyrimidine Metabolism in Man VIII. Advances in Experimental Medicine and Biology, vol 370. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2584-4_47
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2584-4_47
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6105-3
Online ISBN: 978-1-4615-2584-4
eBook Packages: Springer Book Archive